Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Schmidt

Showing results (571-580 of 631) with videos related to

Pageof 64
Sort By:
Immunity|February 4, 2025
NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer's disease progressionRóisín M McManus, Max P Komes, Angelika Griep, et al.
Science Signaling|April 30, 2024
Inhibiting Hippo pathway kinases releases WWC1 to promote AMPAR-dependent synaptic plasticity and long-term memory in miceJens Stepan, Daniel E Heinz, Frederik Dethloff, et al.
The Lancet. Oncology|June 18, 2021
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 studyChung-Han Lee, Amishi Yogesh Shah, Drew Rasco, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegenerationJakob Hartmann, Thomas Bajaj, Joy Otten, et al.
Neuron|June 1, 2022
Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2Juan Pablo Lopez, Malte D Lücken, Elena Brivio, et al.
Nature Communications|November 9, 2023
NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexingWei Feng, Joanne C Beer, Qinyu Hao, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
NULISA: a novel proteomic liquid biopsy platform with attomolar sensitivity and high multiplexingWei Feng, Joanne Beer, Qinyu Hao, et al.
Science Immunology|January 11, 2024
UNC93B1 variants underlie TLR7-dependent autoimmunityChristine Wolf, Ee Lyn Lim, Mohammad Mokhtari, et al.
Journal for Immunotherapy of Cancer|March 17, 2023
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)Sophie Postel-Vinay, Vincent K Lam, Willeke Ros, et al.
The Journal of Clinical Investigation|August 12, 2020
Type 2 diabetes risk gene Dusp8 regulates hypothalamic Jnk signaling and insulin sensitivitySonja C Schriever, Dhiraj G Kabra, Katrin Pfuhlmann, et al.
Pageof 64

Showing results (571-580 of 631) with videos related to

Sort By:
Pageof 64
Immunity|February 4, 2025
NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer's disease progressionRóisín M McManus, Max P Komes, Angelika Griep, et al.
Science Signaling|April 30, 2024
Inhibiting Hippo pathway kinases releases WWC1 to promote AMPAR-dependent synaptic plasticity and long-term memory in miceJens Stepan, Daniel E Heinz, Frederik Dethloff, et al.
The Lancet. Oncology|June 18, 2021
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 studyChung-Han Lee, Amishi Yogesh Shah, Drew Rasco, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegenerationJakob Hartmann, Thomas Bajaj, Joy Otten, et al.
Neuron|June 1, 2022
Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2Juan Pablo Lopez, Malte D Lücken, Elena Brivio, et al.
Nature Communications|November 9, 2023
NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexingWei Feng, Joanne C Beer, Qinyu Hao, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
NULISA: a novel proteomic liquid biopsy platform with attomolar sensitivity and high multiplexingWei Feng, Joanne Beer, Qinyu Hao, et al.
Science Immunology|January 11, 2024
UNC93B1 variants underlie TLR7-dependent autoimmunityChristine Wolf, Ee Lyn Lim, Mohammad Mokhtari, et al.
Journal for Immunotherapy of Cancer|March 17, 2023
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)Sophie Postel-Vinay, Vincent K Lam, Willeke Ros, et al.
The Journal of Clinical Investigation|August 12, 2020
Type 2 diabetes risk gene Dusp8 regulates hypothalamic Jnk signaling and insulin sensitivitySonja C Schriever, Dhiraj G Kabra, Katrin Pfuhlmann, et al.
Pageof 64